Hong Kong targets biomedicine powerhouse status in debut five-year plan
Biomedicine is set to feature in Hong Kong’s first five-year plan, due to be unveiled next week, as the city’s top officials signal closer medical cooperation across the Greater Bay Area.
Lending weight to those ambitions, global pharmaceutical company GSK emphasised its interest in expanding its role in the region’s biotech development on Wednesday, at the fifth Hong Kong International Biotechnology Conference and Exhibition (BIOHK).
Speaking at the event, Hong Kong Secretary for Health Lo...
Scenario chain
Probabilities below are model estimates based on the event chain, horizon, and indicators. They are not outcome guarantees, investment advice, or emergency instructions.
Эскалация
Forecast derived from cascade analysis. Watch confirmation indicators below.
Primary source: South China Morning Post
Ваши вероятности A/B/C
C 33%
Checking access status…